公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2015 | A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results. | Yang, James Chih-Hsin; Srimuninnimit, Vichien; Ahn, Myung-Ju; Lin, Chia-Chi; Kim, Sang-We; Tsai, Chun-Ming; Mok, Tony; Orlando, Mauro; Puri, Tarun; Wang, Xin; Park, Keunchil | J. Clin. Oncol. | | | |
2023 | Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial | Chmielecki, Juliann; Mok, Tony; Wu, Yi-Long; Han, Ji-Youn; Ahn, Myung-Ju; Ramalingam, Suresh S; John, Thomas; Okamoto, Isamu; CHIH-HSIN YANG ; Shepherd, Frances A; Bulusu, Krishna C; Laus, Gianluca; Collins, Barbara; Barrett, J Carl; Hartmaier, Ryan J; Papadimitrakopoulou, Vassiliki | Nature communications | 25 | 16 | |
2022 | Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations | Ahn, Myung-Ju; Mendoza, Marvin Jonne L; Pavlakis, Nick; Kato, Terufumi; Soo, Ross A; Kim, Dong-Wan; Liam, Chong Kin; Hsia, Te-Chun; Lee, Chee Khoon; Reungwetwattana, Thanyanan; Geater, Sarayut; Chan, Oscar Siu Hong; Prasongsook, Naiyarat; Solomon, Benjamin J; Nguyen, Thi Thai Hoa; Kozuki, Toshiyuki; CHIH-HSIN YANG ; Wu, Yi-Long; Mok, Tony Shu Kam; Tan, Daniel Shao-Weng; Yatabe, Yasushi | Clinical lung cancer | 8 | 3 | |
2015 | AZD3759, an EGFR inhibitor with blood brain barrier (BBB) penetration for the treatment of non-small cell lung cancer (NSCLC) with brain metastasis (BM): Preclinical evidence and clinical cases. | Kim, Dong-Wan; Yang, James Chih-Hsin; Chen, Kan; Cheng, Ziqiang; Yin, Lucy; Martin, Paul David; Yang, Zhenfan; Jiang, Haiyi; Ahn, Myung-Ju | J. Clin. Oncol. | | | |
2023 | Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results | Gutierrez, Martin; Lam, Wei-Sen; Hellmann, Matthew D; Gubens, Matthew A; Aggarwal, Charu; Tan, Daniel Shao Weng; Felip, Enriqueta; Chiu, Joanne W Y; Lee, Jong-Seok; CHIH-HSIN YANG ; Garon, Edward B; Finocchiaro, Giovanna; Ahn, Myung-Ju; Luft, Alexander; Landers, Gregory A; Basso, Andrea; Ma, Hua; Kobie, Julie; Palcza, John; Cristescu, Razvan; Fong, Lawrence; Snyder, Alexandra; Yuan, Jianda; Herbst, Roy S | Nature medicine | 2 | 0 | |
2023 | Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 Trial | CHIH-HSIN YANG ; Liu, Geoffrey; Lu, Shun; He, Jianxing; Burotto, Mauricio; Ahn, Myung-Ju; Kim, Dong-Wan; Liu, XiaoQing; Zhao, Yanqiu; Vincent, Sylvie; Yin, Jiani; Ma, Xin; Lin, Huamao M; Popat, Sanjay | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 4 | 0 | |
2023 | Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis | Soo, Ross A; Cho, Byoung Chul; Kim, Joo-Hang; Ahn, Myung-Ju; Lee, Ki Hyeong; Zimina, Anastasia; Orlov, Sergey; Bondarenko, Igor; Lee, Yun-Gyoo; Lim, Yueh Ni; Lee, Sung Sook; Lee, Kyung-Hee; Pang, Yong Kek; Fong, Chin Heng; Kang, Jin Hyoung; Lim, Chun Sen; Danchaivijitr, Pongwut; Kilickap, Saadettin; CHIH-HSIN YANG ; Arslan, Cagatay; Lee, Hana; Park, Seong Nam; Cicin, Irfan | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 1 | | |
2023 | Correction to: Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies | Popat, Sanjay; Ahn, Myung-Ju; Ekman, Simon; Leighl, Natasha B; Ramalingam, Suresh S; Reungwetwattana, Thanyanan; Siva, Shankar; Tsuboi, Masahiro; Wu, Yi-Long; CHIH-HSIN YANG | Targeted oncology | 0 | 0 | |
2023 | Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia | Mitsudomi, Tetsuya; Tan, Daniel; CHIH-HSIN YANG ; Ahn, Myung-Ju; Batra, Ullas; Cho, Byoung-Chul; Cornelio, Gerardo; Lim, Tony; Mok, Tony; Prabhash, Kumar; Reungwetwattana, Thanyanan; Ren, Sheng-Xiang; Singh, Navneet; Toyooka, Shinichi; Wu, Yi-Long; PAN-CHYR YANG ; Yatabe, Yasushi | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 13 | 12 | |
2022 | Final Overall Survival, Safety, and Quality of Life Results From a Phase 2 Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced NSCLC | Wu, Yi-Long; Lu, Shun; CHIH-HSIN YANG ; Zhou, Jianying; Seto, Takashi; Ahn, Myung-Ju; Su, Wu-Chou; Yamamoto, Noboru; Kim, Dong-Wan; Paolini, Jolanda; Usari, Tiziana; Iadeluca, Laura; Wilner, Keith D; Goto, Koichi | JTO clinical and research reports | 4 | 0 | |
2015 | Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) non-small cell lung cancer (NSCLC). | Yang, James Chih-Hsin; Ahn, Myung-Ju; Dickgreber, Nicolas J.; Halmos, Balazs; Hirsh, Vera; Hochmair, Maximilian J.; Levy, Benjamin Philip; De Marinis, Filippo; Mok, Tony; O'Byrne, Kenneth; Okamoto, Isamu; Schuler, Martin H.; Sebastian, Martin; Shah, Riyaz N. H.; Tan, Eng-Huat; Yamamoto, Nobuyuki; Marten, Angela; Massey, Dan; Wind, Sven; Carbone, David Paul | J. Clin. Oncol. | | | |
2023 | Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301 | Cho, Byoung Chul; Ahn, Myung-Ju; Kang, Jin Hyoung; Soo, Ross A; Reungwetwattana, Thanyanan; CHIH-HSIN YANG ; Cicin, Irfan; Kim, Dong-Wan; Wu, Yi-Long; Lu, Shun; Lee, Ki Hyeong; Pang, Yong-Kek; Zimina, Anastasia; Fong, Chin Heng; Poddubskaya, Elena; Sezer, Ahmet; How, Soon Hin; Danchaivijitr, Pongwut; Kim, YuKyung; Lim, Yeji; An, Taewon; Lee, Hana; Byun, Hae Mi; Zaric, Bojan | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 15 | 1 | |
2023 | Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies | Popat, Sanjay; Ahn, Myung-Ju; Ekman, Simon; Leighl, Natasha B; Ramalingam, Suresh S; Reungwetwattana, Thanyanan; Siva, Shankar; Tsuboi, Masahiro; Wu, Yi-Long; CHIH-HSIN YANG | Targeted oncology | 2 | 5 | |
2023 | A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | Razak, Albiruni R Abdul; Wang, Hung-Ming; Chang, Jang-Yang; Ahn, Myung-Ju; Munster, Pamela; Blumenschein, George; Solomon, Benjamin; Lim, Darren Wan-Teck; RUEY-LONG HONG ; Pfister, David; Saba, Nabil F; Lee, Se-Hoon; van Herpen, Carla; Quadt, Cornelia; Bootle, Douglas; Blumenstein, Lars; Demanse, David; Delord, Jean-Pierre | Targeted oncology | 0 | | |
2023 | A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study) | Ang, Yvonne L E; Zhao, Xiaotian; Reungwetwattana, Thanyanan; Cho, Byoung-Chul; BIN-CHI LIAO ; Yeung, Rebecca; Loong, Herbert H; Kim, Dong-Wan; CHIH-HSIN YANG ; Lim, Sun Min; Ahn, Myung-Ju; Lee, Se-Hoon; Suwatanapongched, Thitiporn; Kongchauy, Kanchaporn; Ou, Qiuxiang; Yu, Ruoying; Tai, Bee Choo; Goh, Boon Cher; Mok, Tony S K; Soo, Ross A | Cancers | 1 | 0 | |
2024 | Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study | Subbiah, Vivek; Hu, Mimi I; Mansfield, Aaron S; Taylor, Matthew H; Schuler, Martin; Zhu, Viola W; Hadoux, Julien; Curigliano, Giuseppe; Wirth, Lori; Gainor, Justin F; Alonso, Guzman; Adkins, Douglas; Godbert, Yann; Ahn, Myung-Ju; Cassier, Philippe A; Cho, Byoung Chul; CHIA-CHI LIN ; Zalutskaya, Alena; Barata, Teresa; Trask, Peter; Scalori, Astrid; Bordogna, Walter; Heinzmann, Sebastian; Brose, Marcia S | Thyroid : official journal of the American Thyroid Association | | | |
2015 | Preliminary results of TATTON, a multi-arm phase Ib trial of AZD9291 combined with MEDI4736, AZD6094 or selumetinib in EGFR-mutant lung cancer. | Oxnard, Geoffrey R.; Ramalingam, Suresh S.; Ahn, Myung-Ju; Kim, Sang-We; Yu, Helena Alexandra; Saka, Hideo; Horn, Leora; Goto, Koichi; Ohe, Yuichiro; Cantarini, Mireille; Frewer, Paul; Lahn, Michael; Yang, James Chih-Hsin | J. Clin. Oncol. | | | |
2023 | Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial | Mazieres, Julien; Paik, Paul K; Garassino, Marina C; Le, Xiuning; Sakai, Hiroshi; Veillon, Remi; Smit, Egbert F; Cortot, Alexis B; Raskin, Jo; Viteri, Santiago; Wu, Yi-Long; CHIH-HSIN YANG ; Ahn, Myung-Ju; Ma, Rui; Zhao, Jun; O'Brate, Aurora; Berghoff, Karin; Bruns, Rolf; Otto, Gordon; Johne, Andreas; Felip, Enriqueta; Thomas, Michael | JAMA oncology | 9 | 4 | |
2023 | Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial | Goto, Koichi; Goto, Yasushi; Kubo, Toshio; Ninomiya, Kiichiro; Kim, Sang-We; Planchard, David; Ahn, Myung-Ju; Smit, Egbert F; de Langen, Adrianus Johannes; Pérol, Maurice; Pons-Tostivint, Elvire; Novello, Silvia; Hayashi, Hidetoshi; Shimizu, Junichi; Kim, Dong-Wan; Kuo, Chih-Hsi; CHIH-HSIN YANG ; Pereira, Kaline; Cheng, Fu-Chih; Taguchi, Ayumi; Cheng, Yingkai; Feng, Wenqin; Tsuchihashi, Zenta; Jänne, Pasi A | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 16 | 3 | |
2021 | Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer | Dziadziuszko, Rafal; Krebs, Matthew G; De Braud, Filippo; Siena, Salvatore; Drilon, Alexander; Doebele, Robert C; Patel, Manish R; Cho, Byoung Chul; Liu, Stephen V; Ahn, Myung-Ju; Chiu, Chao-Hua; Farago, Anna F; CHIA-CHI LIN ; Karapetis, Christos S; Li, Yu-Chung; Day, Bann-Mo; Chen, David; Wilson, Timothy R; Barlesi, Fabrice | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 75 | 57 | |